Clinical significance of anti-Jra: Report of two cases and review of the literature

Transfusion

Volumn 44, Issue 2, 2004, Pages 197-201

  Kwon, MeeAe Y ^b   Su, Leon ^b   Arndt, Patricia A ^b   Garratty, George ^b   Blackall, Douglas P ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN; JR A ANTIBODY; JR A ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEURYSM CLIP; ANTIBODY DETECTION; ARTICLE; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; CELL ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOLYSIS; HUMAN; MALE; MONOCYTE MONOLAYER ASSAY; SEROLOGY;

ACUTE DISEASE; AGED; ANTIBODIES; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; FEMALE; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED;

EID: 1242299634     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00643.x     Document Type: Article

References (23)

1. Stroup M, MacIlroy M. Jr-five examples of an antibody defining an antigen of high frequency in the Caucasian population (abstract). Proceedings 23rd Annu Meeting Am Assoc Blood Banks 1970:86.
2. a antigen in the Japanese population. Vox Sang 1978;35:265-7.
3. a. Transfusion 1986;26:543-4.
4. a in two Beduin Arab women in Israel. Transfusion 1986;26:119-20.
5. a mediated hemolytic disease of the newborn infant. Am J Obstet Gynecol 1980;137:135-6.
6. a on the baby: a case report and pedigree chart. Tohoku J Exp Med 1985;145:97-101.
7. a cause hemolytic disease of the newborn? Vox Sang 1981;41:40-4.
8. a. Transfusion 1977;17:177-8.
9. a in a Mexican American. Transfusion 1978;18:569.
10. Yamaguchi H, Okubo Y, Seno T, et al. A rare phenotype blood Jr (a-) occurring in two successive generations of a Japanese family. Proc Jpn Acad 1976;52:521-3.
11. a antibody. Am J Obstet Gynecol 2001;184:75-6.
12. a. Jpn J Transfus Med 1988;34:406-10.
13. a (abstract). Transfusion Med 1994;4(suppl 1):49.
14. a. Transfusion 1976;16:646-7.
15. a. Jpn J Tranfus Med 1991;34:528-30.
16. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;4:297-312.
17. Garratty G, Arndt P, Nance S. The potential clinical significance of blood group alloantibodies to high frequency antigens (abstract). Blood 1997;10 (suppl 1):473a.
18. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
19. Garratty G, Arndt P. Determining the clinical significance of blood group alloantibodies: a reevaluation of the interpretation of monocyte monolayer assay results. Blood 1998;92:563a.
20. a antibodies by monocyte phagocytosis assays and flow cytometry analysis. Acta Haematol Jpn (in Jap) 1990;53:1131-7.
21. a. Vox Sang 1994;66:51-4.
22. Garratty G, Arndt P, Postoway N, Nance S. Severe hemolytic transfusion reactions associated with antibodies not detectable by routine methods. Transfusion 1996;36 (suppl):23S.
23. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. Oxford: Blackwell Science, 1997.